Vigil Neuro
Shannon Ryan is an experienced professional in the healthcare and education sectors, currently serving as a Clinical Project Manager at Vigil Neuroscience since August 2022, after previously holding roles as a Senior Operations Associate and Office Administrator. Prior roles include Care Coordinator at Beth Israel Lahey Health, where responsibilities involved patient support and care management. Shannon's background includes an internship at the Lawrence B. Taishoff Center for Inclusive Higher Education, focusing on the efficacy of inclusive education, and positions as a Student Teaching Assistant and Assistant ESL Teacher, emphasizing educational development and public health awareness. Additional experience as a Philanthropy Coordinator for Alpha Xi Delta involved coordinating fundraising events for Autism Speaks. Shannon holds a Bachelor's degree in Public Health and Psychology from Syracuse University and has studied abroad at the University of Sydney.
This person is not in any offices
Vigil Neuro
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.